PubRank

Hydroxychloroquine With or Without Azithromycin for Virologic Cure of COVID-19

Clinical Trial ID NCT04349592

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04349592

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020 18.32
2 A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. N Engl J Med 2020 10.90
3 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020 10.16
4 A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020 7.78
5 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020 4.49
6 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 2020 3.90
7 Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. JAMA 2015 3.34
8 Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020 2.35
9 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020 2.03
10 Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2005 1.43
11 Full spectrum of COVID-19 severity still being depicted. Lancet 2020 1.39
12 Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020 1.38
13 Zika virus cell tropism in the developing human brain and inhibition by azithromycin. Proc Natl Acad Sci U S A 2016 1.08
14 Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 2013 0.86
15 Coronavirus Spike Protein and Tropism Changes. Adv Virus Res 2016 0.78
16 Covid-19 - The Search for Effective Therapy. N Engl J Med 2020 0.75
Next 100